Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
The FDA approved Wegovy for use in a form of liver disease. www.marketwatch.com #Novo #Nordisk #shares #rising #FDA #approves #Wegovy
Tag: Novo
Stock Movers: Novo Nordisk, Vestas, Babcock (Podcast)
Source: Bloomberg, 4:05 www.bloomberg.com #Stock #Movers #Novo #Nordisk #Vestas #Babcock #Podcast
Cash pay is ‘going to constitute a major part of the Wegovy business’: Novo Nordisk CFO
Novo Nordisk (NVO) reported an earnings miss Wednesday, sending its stock down 4% in early trading, pressuring the stock further…
Novo Soars as Lilly’s Obesity Pill Disappointment Offers Relief
Novo Nordisk A/S shares soared as disappointing data from rival Eli Lilly & Co.’s closely watched obesity pill bolstered investor…
Wegovy maker Novo Nordisk warns of layoffs as competition grows | Business and Economy News
Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be unavoidable as competition…
Trump Ramps Up Tariff Blitz, Novo Nordisk Profit Miss, More
Source: Bloomberg, 0:00 www.bloomberg.com #Trump #Ramps #Tariff #Blitz #Novo #Nordisk #Profit
Novo Nordisk (NVO) earnings Q2 2025
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams…
Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due…
Denmark’s Economy Runs on Novo. Will the Drugmaker’s Troubles Slim It Down?
Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of…
Why Novo Nordisk Stock Imploded This Week
Novo Nordisk shares dropped after slashing full-year sales guidance, primarily due to weakening sales of its blockbuster GLP-1 drugs, Ozempic…